Transcripts from the Xenopus gene GS17 are absent from oocytes and first appear at the midblastula transition (MBT), about 8 hr after fertilization. Iiuection experiments with deletions of the GS17 gene and GS17-f3-globin hybrid genes show that a relatively short sequence of 74 base pairs is sufficient to activate, in cis, transcription at the MBT. This 74-base sequence is located about 700 bases upstream of the GS17 promoter and has the properties of an enhancer element.
The events of early development are regulated by gene products encoded by the maternal and embryonic genomes. In Xenopus, maternal components are responsible for development throughout cleavage and up to the 4000-cell stage, when transcription of the embryonic genome suddenly commences (1, 2) . This transcriptional activation is one of the events that characterizes the midblastula transition (MBT) (3) (4) (5) . Most of the RNA synthesized at the MBT is 5S RNA, tRNA, and small nuclear RNA, which are already present in the egg, but some embryo-specific RNAs are also transcribed at this time (6, 7) . Inhibition of transcription at the MBT prevents gastrulation (8, 9) , and so presumably some of the new embryonic transcripts play important roles in early development. The aim of our current research is to determine the mechanism by which some, but not all, embryonic genes are selected for transcription at the MBT.
In several organisms the mechanism of specific gene activation during early development has been investigated by injecting altered genes into developing embryos. For example, developmentally regulated genes have been studied in Drosophila (10, 11) , mice (12, 13) , and sea urchins (14) . Similarly, we have studied transcriptional regulation in Xenopus development by microinjecting an embryonic gene into fertilized eggs.
The gene that we use in these expression experiments, GS17, is among the very first to be expressed by the embryonic genome. GS17 mRNA first appears at the MBT, reaches maximum levels at gastrulation, and then rapidly disappears during neurulation (7) . We infer from the fact that GS17 comes on precisely at the MBT that its selection for transcriptional activation is controlled by maternal factors. The function of the 17,000-dalton protein encoded by the GS17 mRNA has not been determined. When cloned copies of the GS17 gene are injected into fertilized Xenopus eggs, transcription ofthe injected gene is correctly regulated during subsequent development-i.e., the switch-on and switch-off of transcription occurs at the same time for the injected and the endogenous genes (7) . The GS17 plasmid used in those studies contained 2000 bases of the 5' flanking region of GS17 and we therefore concluded that the signals required for correct developmental expression must be located within this region. By extending these simple expression experiments we have now analyzed the 5' flanking region of GS17 in more detail and identified a transcription enhancer sequence that is located -700 bases upstream from the GS17 promoter. The experiments reported here suggest that this enhancer sequence is necessary for the transcriptional activation of GS17 at the MBT.
MATERIALS AND METHODS
Plasmids and Production of Deletion Constructions. The plasmid p2.OB is derived from pGS17 5' (7). It contains the same fragment of the GS17 gene (about 2000 bases of the 5' flanking sequence and 120 bases ofthe first exon), cloned into pSP64 (15) , but is marked at the 3' end by a 29-base EcoRI-HindIII fragment of pBR322. Plasmid p2.OB was the starting material for the construction of the 5' deletion series. Deletions that removed increasingly longer pieces of the 5' flanking region of the GS17 gene were generated by using a DNase I/MnCl2 procedure (16) , and the resulting plasmids were sized on 1% agarose gels. Plasmids containing end points spaced at about 200-base intervals along the GS17 sequence were selected for expression analysis. The names of the deletion plasmids contain the length [in kilobases (kb)] of the 5' flanking region retained in each construction (see Fig. 1 ).
For analysis of enhancer properties, fragments of GS17 DNA were isolated from the deletion plasmids. The EcoRV site at -605 or the Dra I site at -681 marked the 3' ends of the excised fragments (see Fig. 2 ). EcoRI linkers were added to the EcoRV or Dra I ends of the GS17 DNA fragments and following EcoRI cleavage the enhancer fragment was inserted into the EcoRI site of pX/ (7) . pX/3 contains the entire Xenopus adult l-globin gene (17) , including 471 bases of 5' flanking sequence containing the (-globin promoter.
DNA Sequence Analysis. The DNA sequence of the 5' flanking region ofthe GS17 gene was determined by using the chain-termination procedure of Sanger et al. (18) . Overlapping sequences were obtained by cloning inserts from the deletion constructions into M13 sequencing vector mplO or mpH (19) .
Injection of Fertilized Eggs. Xenopus laevis females were obtained from Xenopus I (Ann Arbor, MI). Injection and incubation of the fertilized eggs were carried out as described (7) . All embryonic stages refer to the timetable of Nieuwkoop and Faber (20) .
RNA Preparation and Analysis of Transcripts. Total RNA was isolated from embryos by proteinase K digestion, phenol/chloroform extraction, and ethanol precipitation as described (21 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (15) . In each case appropriate restriction fragments containing the 5' end of the gene were cloned into the polylinkers of pSP64 or pSP65 (15) . Uniformly labeled RNA probes (6 x 108 dpm/,4g) were synthesized from linear templates using SP6 polymerase as described (15) , except that the reactions were performed at 30'C. Under limiting nucleotide concentrations, incubation at 300C can result in a greater yield of full-length product (22) . The sizes of full-length probe and of the expected RNase-protected fragments are shown in each figure.
RESULTS
Deletion Analysis of the GS17 Promoter. Previous experiments have shown that a 2-kb region of DNA at the 5' end of the GS17 gene is sufficient to provide correct regulation of transcription during early development, from the blastula to neurula stage (7) . To identify the DNA sequences that are required for the transcriptional regulation of GS17, we began by examining the expression of a series of deletion constructions (see Materials and Methods). The deletion constructions used in these studies contain 5' flanking regions ranging from about 1660 bases to 240 bases. These constructions are illustrated in Fig. lA . All constructions contain a short marker sequence so that transcripts from the injected and endogenous GS17 promoters may be distinguished.
Fifty picograms of each DNA to be tested was injected into fertilized Xenopus eggs as supercoiled plasmid DNA and transcription from the GS17 promoter was assayed by RNase protection analysis. Total RNA from injected embryos was assayed at early gastrula (stage 10) when endogenous levels of GS17 mRNA are near maximum. The results of the RNase protection experiment are shown in Fig. 1B . The amount of endogenous GS17 RNA (protected fragment, 116 bases in length) is approximately equal in all tracks, indicating a reproducible recovery of RNA from the injected embryos. The amount of marked transcript derived from the different deletion constructions, however, shows dramatic variation. Though the amounts of transcripts produced by the first six constructions (p2.OB to pO.93D) are approximately equal to each other and similar to the amounts synthesized by the endogenous gene, no marked transcripts are detected in RNA isolated from embryos injected with deletion construction pO.70D, pO.60RV, or pO.24Sc. Southern blot analysis was carried out to determine the amount of plasmid template DNA contained in the injected embryos. These data (not shown) reveal that the amount of template is about equal in each sample, although variations in template concentration do account for the slight variation in amount of marked transcript observed in Fig. 1B . For example, about a 2-fold amplification of the amount of pl.66D template DNA is responsible for the increase in marked transcript in track 2. Despite these small variations, the amount of DNA present for pO.70D, pO.6ORV, and pO.24Sc (tracks 7-9) does not differ significantly from that of the longer constructions (tracks 1-6). Therefore, the major decrease in the amount of transcription from the three shortest deletion constructions does not correlate with a significant decrease in the amount of template DNA. We conclude that a sequence required for efficient expression of the GS17 gene has been removed in pO.70D. This places a critical sequence at least 700 bases upstream of the cap site of the GS17 gene.
DNA Sequence of the 5' Flanking Regions of the GS17 Gene. To help identify and characterize the transcriptional control elements, the DNA sequence of 1000 bases of the flanking sequence of the GS17 gene was determined (see Fig. 2 ). RNase protection experiments have suggested that GS17 mRNA consists of several species that differ slightly in the length of their 5' untranslated regions (7). The residue marked as + 1 in Fig. 2 corresponds to the cap site of the longest but least abundant of these mRNA species. Inspection of the DNA sequences shows that "TATA" and "CATT" boxes are located at the expected positions relative to the cap site, at approximately -30 and -80, respectively. The region of DNA determined to be essential for efficient transcription in the deletion analysis experiments is at least 700 bases upstream of these common promoter elements. This suggested that the upstream region might contain a transcriptional enhancer sequence.
Enhancing Activity of GS17 Sequences on a Heterologous Promoter. The functional effect of an enhancer on a promoter is relatively independent of distance and orientation and, furthermore, an enhancer can stimulate the transcription of a heterologous promoter (for reviews, see refs. [23] [24] [25] . To test the upstream region of the GS17 gene for enhancer activity, we have used the Xenopus major adult p-globin gene as a marker gene. The plasmid pX,8 contains the entire P-globin gene, including about 500 bases of 5' flanking sequence. Our previous experiments (7) and those of others (26) These new protected fragments may be due to initiation of p8-globin transcription at a second cap site. Alternatively, they could result from a transcript initiated within the inverted GS17 sequences and spliced to globin sequences. In the latter case, the GS17 sequences might act as an enhancer and a promoter (for example, see ref. 27 ). These experiments show that a GS17 DNA fragment is capable of greatly increasing transcription from a heterologous promoter and that this GS17 sequence is active in both orientations. In separate experiments, the 350-base fragment was able to activate transcription from the GS17 promoter when placed about 1000 bases 3' to the cap site of the gene (data not shown). We conclude therefore that sequences of the GS17 gene located between -605 and -929 contain a transcriptional enhancer.
To further define the enhancer sequence, we returned to the deletion library and isolated three more clones, this time containing deletion end points that fall between approximately -930 and -760 of the 5' flanking sequence. These putative enhancer fragments were cleaved at the Dra I site at -681, thus removing a further 76 bases from the 3' side of the enhancer fragment tested in the previous experiment. In each case, the GS17 fragment to be tested for enhancer activity was inserted into the EcoRI site of pXl in the positive orientation (see Fig. 4A ). Complete with linker sequences, the fragments of GS17 DNA in plasmids 2, 3, and 4 are about 200, 150, and 90 bases long, respectively. As in previous experiments, 50 pg of each plasmid DNA was injected into fertilized Xenopus eggs and RNA was isolated from stage 10 embryos to determine which deletions enhanced transcription from the globin promoter. The results of the RNase protection assays are shown in Fig. 4B . Again, transcription is not detected from pXB alone (track 5), but each of the deletion constructions containing GS17 DNA significantly enhances f3-globin transcription. The levels of B-globin transcript are about equal for each construction, suggesting that the entire enhancer domain is contained within the shortest fragment of GS17 DNA.
DNA sequencing shows that this short GS17 fragment contains 74 bases of GS17 DNA located between bases -681 and -755 of the 5' flanking sequence. A number of other enhancer domains-for example, those associated with the human P-interferon gene (28) , the human a-interferon gene (29) , Xenopus ribosomal genes (30, 31) , and mouse afetoprotein genes (32)-contain repeated elements and in some cases, maximum transcriptional activity is only obtained when all of the repeated elements are present. The 74-base region of GS17 does not contain any long direct or inverted repeats and sequences within this 74-base domain are not homologous to other sequences in the 5' flanking region of the GS17 gene. We do note that the sequence CCCCT appears four times within the 74-bp region and this high GC content is reminiscent of the CCGCCC sequence found in the simian virus 40 enhancer. Comparison of the GS17 enhancer with the transcriptional control regions identified for Xenopus U1 and U2 small nuclear RNA genes (33, 34) does not reveal any striking homology. This is perhaps surprising because these small nuclear RNA genes are transcriptionally activated at the MBT (35) .
DISCUSSION
The aim of our experiments was to investigate the transcriptional regulation of genes expressed early in Xenopus em- bryogenesis and, in particular, to determine how some genes, but not others, are selected for transcription at the MBT. In this report we have identified at least one element of this regulatory machinery-namely, a cis-acting element located about 700 bases upstream of the GS17 promoter that has all of the properties of a typical transcriptional enhancer.
GS17 sequences are expressed for only a few hours during early embryogenesis. Transcription of the gene commences at the MBT and stops at about midgastrula, after which time the GS17 mRNA rapidly disappears (7) . Using fertilized Xenopus eggs as an expression system we showed that injected copies of the GS17 gene exhibit a transcription profile identical to that of the endogenous gene. Experiments described in this paper delineate the regulatory sequences required for this transcriptional activation GS17. Deletion of sequences greater than about 800 bases upstream of the GS17 promoter has no noticeable effect on transcription of the injected gene, but deletion of sequences that contain the enhancer element causes transcription to drop below detectable levels. Furthermore, we have shown that insertion ofthe GS17 enhancer into a plasmid construction can cause heterologous genes to be efficiently transcribed during early development. Placing the GS17 enhancer next to the Xenopus p8-globin gene results in abundant transcription from the f3-globin promoter, commencing at the MBT. Our analysis of the GS17 promoter has not been exhaustive and it is possible that other regulatory elements are present in the 5' flanking region of the GS17 gene. Nonetheless, our results show that an enhancer plays an important role in regulating the transcription of GS17 sequences at the MBT.
The GS17 enhancer could mediate its effect as a site for some DNA modifications-e.g., methylation-but increasing evidence suggests that enhancers are binding sites for transacting cellular factors. For example, soluble factors bind to enhancers for an immunoglobulin heavy chain gene (36, 37) , an insulin gene (38) , and Xenopus ribosomal genes (31) and to enhancers of several viruses, including simian virus 40 (39, 40) , polyoma (40) , and murine sarcoma virus (39) . If a trans-acting factor does indeed mediate transcription of the GS17 gene, several mechanisms for regulation can be suggested. For example, a trans-acting factor could be present in cleavage-stage embryos, perhaps bound to the GS17 enhancer sequence, but a general repressor of transcription such as that proposed by Newport and Kirschner (5) would prevent the expression of GS17 and other genes until the MBT. Alternatively, the factor might only be synthesized (or activated) at the MBT, leading to an immediate activation of the GS17 promoter. In either case, a trans-acting factor interacting with the GS17 gene is of particular interest because it must be of maternal origin. The absence of embryonic transcription prior to the MBT requires that the factor be stored as a maternal protein or as a maternal mRNA. Although our experiments have not investigated whether the enhancer is involved in the turn-off of GS17 transcription at midgastrula, it is plausible that the switch-on and switch-off of GS17 transcription is brought about by the appearance and disappearance of a regulatory protein that interacts with the enhancer.
Further experiments directed toward the identification and characterization of factors that bind to the GS17 enhancer sequence are necessary. Specifically, the presence of a trans-acting factor in the embryo may provide insight into the mechanism ofregulation of GS17 expression. Recently, it has been shown that correct tissue-specific expression is obtained when Xenopus actin genes are injected into developing eggs (41, 42) . Thus, it may soon be possible to compare the transcriptional regulation of GS17 with actin and other genes that are expressed early in Xenopus development.
